LLY Jan 2025 540.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 02:22PM EDT. Market open.
| Previous close | 267.94 |
| Open | 265.50 |
| Bid | 238.30 |
| Ask | 242.95 |
| Strike | 540.00 |
| Expiry date | 2025-01-17 |
| Day's range | 265.50 - 271.16 |
| Contract range | N/A |
| Volume | |
| Open interest | 926 |
Yahoo FinanceNovo Nordisk sales up 26% driven by GLP-1s, misses 11% on Wegovy
Novo Nordisk CEO Lars Jørgensen tells Yahoo Finance the company is confident about a robust GLP-1 sales year despite missing Wall Street estimates.
Barrons.comNovo Nordisk’s Wegovy Sales More Than Doubled. Why the Stock Is Falling.
The Danish pharmaceutical firm, Europe’s most valuable company, said sales of the weight-loss drug jumped 106% in the first quarter.
Insider MonkeyEli Lilly and Company (NYSE:LLY) Q1 2024 Earnings Call Transcript
Eli Lilly and Company (NYSE:LLY) Q1 2024 Earnings Call Transcript April 30, 2024 Eli Lilly and Company beats earnings expectations. Reported EPS is $2.58, expectations were $2.47. Operator: Ladies and gentlemen, thank you for standing by, and welcome to the Lilly Q1 2024 Earnings Call. At this time all participants are in a listen-only mode. […]
© 2024 Yahoo. All rights reserved.